Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 208 followers
Latest posts
Last updated about 1 hour ago
STAT+: There’s now a chance for bipartisan health care policies, but partisan tensions are running high
about 1 hour ago
WASHINGTON — Republicans’ first major policy bill this year was a partisan...
Opinion: A patient told me that I hadn’t listened closely enough. I’m glad she did
about 1 hour ago
Recently, a long-standing patient came in for her routine office follow-up appointment...
Opinion: Will future med students like me get the same chances I did?
about 1 hour ago
I was 5 when I decided I wanted to become an OB-GYN...
STAT+: California stem cell agency shutting down unique human tissue biobank
about 1 hour ago
The California Institute for Regenerative Medicine has for a decade owned a...
STAT+: Academic groups finalize counterproposal to Trump’s research overhead cuts
about 9 hours ago
A coalition of academic organizations has finalized a proposed alternative to the...
NIH grant cuts, FDA transparency questions, and biotech M&A
about 14 hours ago
On this week’s episode of “The Readout LOUD”: a closer look at...
FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility
about 16 hours ago
Moderna’s Covid-19 vaccine for children has been given full Food and Drug...
STAT+: FDA won’t pay 2024 bonuses to workers who are getting laid off
about 19 hours ago
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about...
STAT+: FDA publishes rejection letters sent to drugmakers, with a big caveat
about 20 hours ago
The Food and Drug Administration on Thursday published more than 200 letters...
STAT+: Brawl over Eylea gets biosimilar industry’s attention
about 20 hours ago
Hello! Today, we talk about a cool experimental enzyme therapy, observe more...
STAT+: Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
about 20 hours ago
Top of the morning to you. And a fine one it is...
STAT+: Eyes on Soleno’s Prader-Willi drug launch
about 23 hours ago
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter...